AND THE THIRD ANGEL FOLLOWED THEM, SAYING WITH A LOUD VOICE, IF ANY MAN WORSHIP THE BEAST AND HIS IMAGE, AND RECEIVE HIS MARK IN HIS FOREHEAD, OR IN HIS HAND. *** REVELATION 14:9
Showing posts with label Pharmakeia. Show all posts
Showing posts with label Pharmakeia. Show all posts
Saturday, August 22, 2026
Friday, April 24, 2026
How RFK Jr. Is Influencing America's Vaccine Playbook
Since taking the helm of HHS, Robert F. Kennedy Jr. has both backed vaccination as a public health tool and taken steps to undermine it.
By Cecelia Smith-Schoenwalder Senior Writer
April 23, 2026, at 11:51 a.m.

ILLUSTRATION BY USN&WR | SOURCE: GETTY IMAGES
Since his confirmation to lead the Department of Health and Human Services, Robert F. Kennedy Jr. has toed the line between backing vaccination as a preventive public health tool and making statements or overseeing developments that threaten to undermine that tool.
Here's a look at notable vaccine-related moves and remarks made by Kennedy or under his authority since he was sworn in as head of HHS in February of 2025.
Jump to a section:
Changing Vaccine Policy
Replacing the Panel That Recommends Vaccines
A Federal Study of the (Debunked) Link Between Vaccines and Autism
Re-examining the Childhood Vaccine Schedule
Vaccine Official Shakeups
Conflicting Comments on the Measles Outbreak
Cutting Research and Delaying Studies on Vaccines
Plan to Shake Up Vaccine Injury Program
Childhood Vaccine Task Force Revival
Friday, January 16, 2026
Friday, August 01, 2025
Saturday, July 12, 2025
Tuesday, January 28, 2025
Friday, June 07, 2024
Thursday, October 19, 2023
Tuesday, August 29, 2023
Vivek Ramaswamy is worth $950 million. Here’s how he became rich
By
Ariel Zilber
August 24, 2023 12:39pm
Updated
Roseanne Barr teams
Vivek Ramaswamy, the 38-year-old Republican presidential candidate who emerged from nowhere to challenge Florida Gov. Ron DeSantis for second place in the GOP primary race, is one of the wealthiest Americans under the age of 40.
Ramaswamy, the son of Indian immigrants who studied biology at Harvard before obtaining a law degree from Yale, was briefly a billionaire before a downturn in the stock market shrunk his wealth to just over $950 million, according to Forbes.
MORE ON:VIVEK RAMASWAMY
Vivek Ramaswamy asks why he should vote for presidential candidate ‘with least experience’ in resurfaced 2004 clip
Ramaswamy cites campaign duties as excuse to skip deposition over major buyout
Ramswamy stands by dis of Dem Rep. Pressley as among ‘wizards of the grand KKK’
DeSantis gains in post-debate poll as Trump touts lead over Biden
He derives most of his fortune from the 10% ownership stake in Roivant Sciences, the biotechnology firm that he founded in 2014.
Ramaswamy, who was raised in the Hindu faith by his parents but went to a Catholic high school, was a hedge fund analyst at QVT before he started Roivant at the age of 29.
He conceived of Roivant as a company that would create subsidiaries that would develop drugs that were overlooked and abandoned by larger pharmaceutical makers.
One of his first major business moves was to acquire the rights to an Alzheimer’s medication that was developed by GlaxoSmithKline and make the drug the centerpiece of a Roivant subsidiary, Axovant.

GOP presidential hopeful Vivek Ramaswamy has amassed a fortune worth $950 million at the age of 38.AP
The drug, intepirdine, showed promising results in early clinical trials, enabling Roivant to take Axovant public in a 2015 IPO that raised $360 million.
In 2017, Roivant raised $1.1 billion in equity from several venture capital firms, including SoftBank.
Ramaswamy took Roivant public in 2021 through a merger with a blank-check firm that valued the company at $7.3 billion.

The drug, intepirdine, showed promising results in early clinical trials, enabling Roivant to take Axovant public in a 2015 IPO that raised $360 million.
In 2017, Roivant raised $1.1 billion in equity from several venture capital firms, including SoftBank.
Ramaswamy took Roivant public in 2021 through a merger with a blank-check firm that valued the company at $7.3 billion.

Ramaswamy earned a biology degree from Harvard before going on to Yale Law School.Getty Images
Since founding Roivant, Ramaswamy has taken in more than $260 million in salary, bonuses, and capital gains.
Ramaswamy’s 10% stake in the company, which had a market capitalization of $8.87 billion as of Thursday morning, translates into $887 million on paper.
So far this year, Roivant’s stock price is up by more than 82%.

Since founding Roivant, Ramaswamy has taken in more than $260 million in salary, bonuses, and capital gains.
Ramaswamy’s 10% stake in the company, which had a market capitalization of $8.87 billion as of Thursday morning, translates into $887 million on paper.
So far this year, Roivant’s stock price is up by more than 82%.

Ramaswamy derives most of his wealth from the 10% ownership stake in biotech firm Roivant.AP
Ramaswamy has also diversified his investments to include cryptocurrency as well as stakes in YouTube upstart rival Rumble and digital payments firm MoonPay, according to Forbes.
He also founded an “anti-woke” index fund, Strive Asset Manager, which was recently valued at $300 million.
Ramaswamy has also diversified his investments to include cryptocurrency as well as stakes in YouTube upstart rival Rumble and digital payments firm MoonPay, according to Forbes.
He also founded an “anti-woke” index fund, Strive Asset Manager, which was recently valued at $300 million.

He conceived of Roivant as a company that would create subsidiaries that would develop drugs that were overlooked and abandoned by larger pharmaceutical makers.roivant.com
Ramaswamy’s stake in Strive is said to be worth $100 million.
In recent years Ramaswamy has become a fierce conservative.
In his 2021 bestseller “Woke, Inc.,” Ramaswamy decries decisions by some big companies to base business strategy around social justice and climate change concerns and lambastes “wokeism” as an insidious influence on hard work, capitalism, religious faith, and patriotism.
The book raised Ramaswamy’s profile among conservatives, and he began his rapid ascension as a right-wing star.
Ramaswamy’s stake in Strive is said to be worth $100 million.
In recent years Ramaswamy has become a fierce conservative.
In his 2021 bestseller “Woke, Inc.,” Ramaswamy decries decisions by some big companies to base business strategy around social justice and climate change concerns and lambastes “wokeism” as an insidious influence on hard work, capitalism, religious faith, and patriotism.
The book raised Ramaswamy’s profile among conservatives, and he began his rapid ascension as a right-wing star.
Saturday, June 10, 2023
DECEIVED BY PHARMAKEIA part-1, "God's Preparation For The End-Time Heal...
Part-2 "Caught in its Snare"
Part-3, "For Such A time As This"
Thursday, March 16, 2023
Tuesday, March 07, 2023
Thursday, February 02, 2023
Wednesday, February 01, 2023
Tuesday, January 31, 2023
Thursday, January 26, 2023
Wednesday, December 28, 2022
Monday, December 26, 2022
Subscribe to:
Posts (Atom)